AMP Stock Cash Flow Statements

Ameriprise Financial Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Ameriprise Financial Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-09-30	2012-06-30	2012-03-31

cash flows from operating activities
net income	1,060,000,000	583,000,000	511,000,000	829,000,000	990,000,000	377,000,000	872,000,000	890,000,000	417,000,000	494,000,000	548,000,000	756,000,000	761,000,000	701,000,000	1,031,000,000	591,000,000	437,000,000	177,000,000	-140,000,000	335,000,000	364,000,000	380,000,000	352,000,000	476,000,000	479,000,000	515,000,000	380,000,000	449,000,000	281,000,000	365,000,000	151,000,000	170,000,000	248,000,000
adjustments to reconcile net income to net cash from operating activities:
depreciation, amortization and accretion	-27,000,000	-27,000,000	-36,000,000	-47,000,000	-42,000,000	-40,000,000	-44,000,000	-35,000,000	-35,000,000	-29,000,000	-7,000,000	8,000,000	-12,000,000	3,000,000	-25,000,000	60,000,000	60,000,000	57,000,000	54,000,000	62,000,000	65,000,000	63,000,000	62,000,000	57,000,000	66,000,000	63,000,000	64,000,000	59,000,000	58,000,000	58,000,000	58,000,000	54,000,000	56,000,000
deferred income tax expense	202,000,000	-95,000,000	-89,000,000	31,000,000	227,000,000	-88,000,000	46,000,000	108,000,000	-48,000,000	-181,000,000	24,000,000	-1,000,000	154,000,000	-150,000,000	-98,000,000	101,000,000	60,000,000	-519,000,000	-323,000,000	-90,000,000	36,000,000			22,000,000	66,000,000	-37,000,000			-23,000,000	41,000,000
share-based compensation	46,000,000	49,000,000	48,000,000	48,000,000	42,000,000	49,000,000	46,000,000	46,000,000	46,000,000	43,000,000	41,000,000	42,000,000	44,000,000	28,000,000	50,000,000	39,000,000	35,000,000	39,000,000	35,000,000	34,000,000	34,000,000	37,000,000	38,000,000	35,000,000	35,000,000	30,000,000	37,000,000	35,000,000	38,000,000	33,000,000	32,000,000	34,000,000	32,000,000
net realized investment (gains) losses	15,000,000	-5,000,000		-1,000,000	-1,000,000	0				4,000,000				-5,000,000	-548,000,000	-14,000,000	-65,000,000	-8,000,000	-4,000,000
net trading (gains) losses	-1,000,000	-1,000,000	-1,000,000	-2,000,000	-2,000,000	-3,000,000	13,000,000	-10,000,000	-9,000,000	8,000,000	5,000,000			2,000,000	0	2,000,000	1,000,000	-1,000,000	-3,000,000
income from equity method investments	-4,000,000	13,000,000	-2,000,000	11,000,000	4,000,000	8,000,000	2,000,000	6,000,000	11,000,000	11,000,000	7,000,000	6,000,000	12,000,000	17,000,000	25,000,000	21,000,000	12,000,000	8,000,000	19,000,000	11,000,000	9,000,000		8,000,000	9,000,000	5,000,000						0
impairments and benefit from loan and credit losses	1,000,000	-5,000,000			-1,000,000	-1,000,000	-6,000,000	-14,000,000	5,000,000	5,000,000	84,000,000
net (gains) losses of consolidated investment entities	-5,000,000	12,000,000	3,000,000	-1,000,000	3,000,000	5,000,000	5,000,000	7,000,000	6,000,000	12,000,000	1,000,000	1,000,000	3,000,000	-3,000,000	3,000,000	-1,000,000	-19,000,000	14,000,000	-20,000,000
changes in operating assets and liabilities:
restricted and segregated investments	319,000,000	158,000,000	-184,000,000	340,000,000	-158,000,000	99,000,000	-320,000,000	336,000,000	-123,000,000	150,000,000	-48,000,000	-74,000,000	-124,000,000	126,000,000	164,000,000	50,000,000	-315,000,000
deferred acquisition costs	14,000,000	16,000,000	8,000,000	7,000,000	12,000,000	12,000,000	12,000,000	17,000,000	23,000,000	-193,000,000	61,000,000	100,000,000	43,000,000	-28,000,000	-58,000,000	-10,000,000	-60,000,000	-138,000,000	31,000,000	3,000,000	28,000,000	-45,000,000	41,000,000	2,000,000	-5,000,000	8,000,000	-34,000,000
policyholder account balances, future policy benefits and claims, and market risk benefits	1,238,000,000	940,000,000	1,837,000,000	1,160,000,000	448,000,000	1,840,000,000	78,000,000	80,000,000	1,073,000,000
derivatives, net of collateral	-545,000,000	270,000,000	-397,000,000	-720,000,000	-51,000,000	-193,000,000	76,000,000	-265,000,000	-242,000,000	-150,000,000	506,000,000	-37,000,000	-4,000,000	-280,000,000	-168,000,000	-266,000,000	144,000,000	-406,000,000	532,000,000	-278,000,000	-382,000,000	273,000,000	-436,000,000	521,000,000	-265,000,000	-85,000,000	612,000,000	378,000,000
receivables	117,000,000	-220,000,000	266,000,000			-48,000,000	-155,000,000	223,000,000	256,000,000	176,000,000	79,000,000	-128,000,000	-83,000,000	-160,000,000	-124,000,000	2,000,000	-238,000,000	-432,000,000	-85,000,000	36,000,000	-62,000,000	17,000,000	-16,000,000	-94,000,000	-184,000,000	-144,000,000	-129,000,000
brokerage deposits	-121,000,000	-25,000,000	357,000,000	-202,000,000	90,000,000	-166,000,000	-51,000,000	-250,000,000	-314,000,000	-177,000,000	-196,000,000	-92,000,000	120,000,000	71,000,000	59,000,000	-2,000,000	-102,000,000	141,000,000	13,000,000	39,000,000	-108,000,000	286,000,000	46,000,000	-105,000,000	110,000,000	60,000,000	220,000,000						23,000,000
accounts payable and accrued expenses	179,000,000	-452,000,000	189,000,000	220,000,000	-436,000,000	290,000,000	117,000,000	166,000,000	-219,000,000	195,000,000	-181,000,000	228,000,000	-461,000,000	154,000,000	-7,000,000	316,000,000	-163,000,000	223,000,000	111,000,000	99,000,000	-295,000,000	123,000,000	103,000,000	52,000,000	-196,000,000	-183,000,000	72,000,000
current income tax	-593,000,000	180,000,000	97,000,000	121,000,000	-44,000,000	-49,000,000	67,000,000	-485,000,000	80,000,000	177,000,000	-102,000,000	68,000,000	-27,000,000
other operating assets and liabilities of consolidated investment entities	5,000,000	2,000,000	4,000,000	-2,000,000	-1,000,000	3,000,000	0	-2,000,000	-6,000,000	1,000,000	-1,000,000	-6,000,000	8,000,000	5,000,000	7,000,000	4,000,000	4,000,000	-35,000,000	26,000,000	2,000,000	-12,000,000	41,000,000	10,000,000	48,000,000	-4,000,000	-14,000,000	8,000,000	-57,000,000			-1,000,000
other	-136,000,000	293,000,000	430,000,000	-28,000,000	364,000,000	49,000,000	123,000,000	-261,000,000	135,000,000	-2,000,000	-58,000,000	192,000,000	159,000,000	-45,000,000	-353,000,000	177,000,000	284,000,000	98,000,000	-122,000,000	45,000,000	207,000,000	-226,000,000	66,000,000	27,000,000	544,000,000	259,000,000	-123,000,000	112,000,000	-62,000,000	74,000,000	87,000,000	-120,000,000	404,000,000
net cash from operating activities	1,764,000,000	1,686,000,000	3,048,000,000	1,720,000,000	1,444,000,000	2,143,000,000	925,000,000	561,000,000	1,056,000,000	1,217,000,000	1,372,000,000	1,409,000,000	409,000,000	1,551,000,000	843,000,000	1,931,000,000	-1,000,000,000	-1,016,000,000	936,000,000	724,000,000	621,000,000	669,000,000	371,000,000	619,000,000	913,000,000	434,000,000	258,000,000				415,000,000	293,000,000	175,000,000
cash flows from investing activities
available-for-sale securities:
proceeds from sales	498,000,000	1,075,000,000	1,779,000,000			8,000,000	397,000,000	16,000,000	313,000,000	568,000,000	436,000,000			1,000,000	150,000,000	313,000,000	92,000,000	18,000,000	372,000,000	160,000,000	154,000,000	143,000,000	95,000,000	8,000,000	48,000,000	161,000,000	0	58,000,000	100,000,000	169,000,000	450,000,000	50,000,000	100,000,000
maturities, sinking fund payments and calls	4,262,000,000	4,221,000,000	3,981,000,000	3,872,000,000	3,283,000,000	2,570,000,000	2,229,000,000	2,967,000,000	1,464,000,000	1,772,000,000	1,859,000,000	1,781,000,000	2,209,000,000	2,509,000,000	3,278,000,000	2,750,000,000	2,964,000,000	2,986,000,000	2,406,000,000	1,428,000,000	956,000,000	1,089,000,000	954,000,000	1,148,000,000	1,351,000,000	1,104,000,000	1,275,000,000	1,371,000,000	1,206,000,000	1,249,000,000	1,333,000,000	1,161,000,000	1,174,000,000
purchases	-3,808,000,000	-6,834,000,000	-5,007,000,000	-3,647,000,000	-3,972,000,000	-4,500,000,000	-4,096,000,000	-6,000,000,000	-5,098,000,000	-6,582,000,000	-6,531,000,000	-4,949,000,000	-3,972,000,000	-4,671,000,000	-3,837,000,000	-2,965,000,000	-3,245,000,000	-3,328,000,000	-4,059,000,000	-1,744,000,000	-1,366,000,000	-1,222,000,000	-1,002,000,000	-1,131,000,000	-1,207,000,000	-1,029,000,000	-1,686,000,000
proceeds from sales, maturities and repayments of mortgage loans	49,000,000	37,000,000	38,000,000	58,000,000	32,000,000	44,000,000	33,000,000	34,000,000	41,000,000	58,000,000	40,000,000	39,000,000	32,000,000	57,000,000	69,000,000	118,000,000	55,000,000	71,000,000	54,000,000	147,000,000	410,000,000
funding of mortgage loans	-133,000,000	-107,000,000	-104,000,000	-136,000,000	-69,000,000	-97,000,000	-64,000,000	-71,000,000	-52,000,000		-31,000,000	-65,000,000	-51,000,000	-97,000,000	-46,000,000	-98,000,000	-22,000,000	-18,000,000	-15,000,000	-109,000,000	-119,000,000	-131,000,000	-159,000,000	-177,000,000	-91,000,000	-124,000,000
proceeds from sales, maturities and collections of other investments	29,000,000	22,000,000	35,000,000	47,000,000	20,000,000	30,000,000	55,000,000	29,000,000	31,000,000	48,000,000	15,000,000	18,000,000	15,000,000	18,000,000	43,000,000	58,000,000	54,000,000	59,000,000	30,000,000
purchase of other investments	-15,000,000	-26,000,000	-21,000,000	-109,000,000	-23,000,000	-43,000,000	-33,000,000	-16,000,000	-24,000,000	-24,000,000	-14,000,000	-56,000,000	-5,000,000	-24,000,000	-19,000,000	-23,000,000	-31,000,000	-65,000,000	-85,000,000	-40,000,000	-46,000,000	-57,000,000	-107,000,000	-49,000,000	-93,000,000	-111,000,000	-80,000,000
purchase of investments by consolidated investment entities	-377,000,000	-354,000,000	-345,000,000	-315,000,000	-131,000,000	-80,000,000	-92,000,000	-133,000,000	-122,000,000	-198,000,000	-396,000,000	-177,000,000	-190,000,000	-142,000,000	-283,000,000	-441,000,000	-737,000,000	-278,000,000	-303,000,000	-158,000,000	-158,000,000	-615,000,000	-820,000,000	-840,000,000	-403,000,000	-742,000,000	-640,000,000
proceeds from sales, maturities and repayments of investments by consolidated investment entities	259,000,000	167,000,000	214,000,000	250,000,000	236,000,000	151,000,000	144,000,000	166,000,000	182,000,000	149,000,000	154,000,000	129,000,000	183,000,000	197,000,000	294,000,000	316,000,000	240,000,000	152,000,000	111,000,000	275,000,000	182,000,000	580,000,000	570,000,000	463,000,000	396,000,000	418,000,000	389,000,000	378,000,000	1,147,000,000	690,000,000	469,000,000	682,000,000	468,000,000
purchase of land, buildings, equipment and software	-38,000,000	-36,000,000	-49,000,000	-17,000,000	-52,000,000	-50,000,000	-50,000,000	-43,000,000	-41,000,000	-56,000,000	-42,000,000	-40,000,000	-44,000,000	-34,000,000	-31,000,000	-33,000,000	-22,000,000	-40,000,000	-45,000,000	-8,000,000	-28,000,000	-24,000,000	-42,000,000	-38,000,000	-29,000,000	-20,000,000	-37,000,000
cash paid for written options with deferred premiums			0	0	-57,000,000	0	0	0	-59,000,000	-208,000,000	-291,000,000			-238,000,000	-104,000,000	1,000,000	-211,000,000	-46,000,000	-34,000,000
cash received from written options with deferred premiums			0	7,000,000	15,000,000	0	12,000,000	7,000,000	24,000,000	63,000,000	54,000,000	75,000,000	12,000,000	46,000,000	36,000,000	3,000,000	21,000,000	4,000,000	21,000,000
cash paid for deposit receivables	-7,000,000	-8,000,000	-8,000,000	-8,000,000	-9,000,000	-9,000,000	-10,000,000	-10,000,000	-10,000,000	-11,000,000	-11,000,000	-11,000,000	-12,000,000
cash received for deposit receivables	117,000,000	112,000,000	143,000,000	160,000,000	167,000,000	195,000,000	172,000,000	197,000,000	210,000,000	157,000,000	130,000,000	129,000,000	134,000,000
net cash from investing activities	802,000,000	-1,741,000,000	635,000,000	166,000,000	-569,000,000	-1,920,000,000	-1,322,000,000	-2,874,000,000	-3,146,000,000	-4,342,000,000	-4,649,000,000	-2,927,000,000	-1,665,000,000	-3,007,000,000	-464,000,000	-100,000,000	-809,000,000	-473,000,000	-1,525,000,000	61,000,000	2,000,000	-67,000,000	-265,000,000	-364,000,000	182,000,000	-145,000,000	-659,000,000	-833,000,000	301,000,000	389,000,000	940,000,000
see notes to consolidated financial statements.
consolidated statements of cash flows
cash flows from financing activities
investment certificates:
proceeds from additions	791,000,000	961,000,000	1,032,000,000	1,213,000,000	1,638,000,000	2,621,000,000	2,177,000,000	2,805,000,000	3,590,000,000	4,499,000,000	2,009,000,000	1,102,000,000	733,000,000	729,000,000	607,000,000	674,000,000	723,000,000	831,000,000	894,000,000	1,009,000,000	1,159,000,000	957,000,000	807,000,000	713,000,000	662,000,000	617,000,000	624,000,000	619,000,000	516,000,000	589,000,000	539,000,000	242,000,000	185,000,000
maturities, withdrawals and cash surrenders	-1,584,000,000	-1,471,000,000	-1,560,000,000	-1,912,000,000	-1,881,000,000	-1,760,000,000	-1,637,000,000	-1,820,000,000	-1,822,000,000	-1,397,000,000	-1,092,000,000	-1,015,000,000	-835,000,000	-870,000,000	-913,000,000	-1,183,000,000	-1,224,000,000	-1,236,000,000	-1,181,000,000	-790,000,000	-807,000,000	-656,000,000	-626,000,000	-668,000,000	-559,000,000	-528,000,000	-528,000,000
policyholder account balances:
deposits and other additions	336,000,000	254,000,000	345,000,000	391,000,000	358,000,000	443,000,000	304,000,000	390,000,000	339,000,000	403,000,000	279,000,000	202,000,000	285,000,000	422,000,000	380,000,000	367,000,000	384,000,000	447,000,000	428,000,000	518,000,000	481,000,000	547,000,000	530,000,000	514,000,000	470,000,000	494,000,000
net transfers from (to) separate accounts	-35,000,000	-36,000,000	-53,000,000	-45,000,000	-26,000,000	-43,000,000	-34,000,000	-36,000,000	-19,000,000	-34,000,000	-38,000,000	-33,000,000	-57,000,000	-67,000,000	-74,000,000	-72,000,000	-60,000,000	-62,000,000	-48,000,000	50,000,000	33,000,000
surrenders and other benefits	-356,000,000	-395,000,000	-425,000,000	-465,000,000	-495,000,000	-563,000,000	-479,000,000	-491,000,000	-569,000,000	-470,000,000	-340,000,000	-321,000,000	-328,000,000	-363,000,000	-309,000,000	-325,000,000	-368,000,000	-322,000,000	-309,000,000	-492,000,000	-497,000,000	-545,000,000	-603,000,000	-778,000,000	-788,000,000	-661,000,000	-1,084,000,000
change in banking deposits	-172,000,000	363,000,000	265,000,000	138,000,000	-170,000,000	527,000,000	38,000,000	926,000,000	1,702,000,000	-288,000,000	3,072,000,000	2,299,000,000	1,802,000,000	1,604,000,000	1,144,000,000	688,000,000	580,000,000	1,084,000,000	1,022,000,000
cash paid for purchased options with deferred premiums	-37,000,000	-3,000,000	-43,000,000	-28,000,000	-51,000,000	-4,000,000	-5,000,000	-20,000,000	-24,000,000	-38,000,000	-42,000,000	-46,000,000	-71,000,000	-62,000,000	-18,000,000	-34,000,000	-42,000,000	-34,000,000	-46,000,000	-78,000,000	-85,000,000	-87,000,000	-89,000,000	-127,000,000	-89,000,000	-124,000,000	-106,000,000
cash received for purchased options with deferred premiums			99,000,000
issuance of long-term debt, net of issuance costs	0	740,000,000				594,000,000	0	0	741,000,000
repayments of long-term debt	-503,000,000	-3,000,000	-3,000,000	-2,000,000	-3,000,000	-752,000,000	-3,000,000	-3,000,000	-2,000,000	-3,000,000	-2,000,000	-3,000,000	-502,000,000	-3,000,000	-2,000,000	-2,000,000	-2,000,000	-2,000,000	-4,000,000	-232,000,000	-19,000,000
dividends paid to shareholders	-152,000,000	-144,000,000	-145,000,000	-147,000,000	-138,000,000	-136,000,000	-139,000,000	-141,000,000	-134,000,000	-133,000,000	-135,000,000	-137,000,000	-129,000,000	-127,000,000	-129,000,000	-126,000,000	-129,000,000	-122,000,000	-125,000,000	-124,000,000	-115,000,000	-117,000,000	-119,000,000	-122,000,000	-107,000,000	-100,000,000	-101,000,000
repurchase of common shares	-581,000,000	-730,000,000	-582,000,000	-573,000,000	-628,000,000	-467,000,000	-545,000,000	-498,000,000	-617,000,000	-488,000,000	-501,000,000	-448,000,000	-541,000,000	-563,000,000	-556,000,000	-441,000,000	-470,000,000	-405,000,000	-320,000,000	-420,000,000	-481,000,000	-448,000,000	-467,000,000	-432,000,000	-394,000,000	-457,000,000	-378,000,000
borrowings of consolidated investment entities	387,000,000	304,000,000	329,000,000	388,000,000	166,000,000					0
repayments of debt by consolidated investment entities	-34,000,000	-328,000,000	-434,000,000	-117,000,000	-227,000,000	-78,000,000	-102,000,000	-64,000,000	-31,000,000	-3,000,000	0	0	-1,000,000	-385,000,000	-3,000,000	-691,000,000	-63,000,000	-19,000,000	-18,000,000	-34,000,000	-26,000,000	-314,000,000	-144,000,000	-69,000,000	-192,000,000	-85,000,000	-77,000,000
net cash from financing activities	-1,940,000,000	-488,000,000	-1,173,000,000	-1,103,000,000	-1,431,000,000	381,000,000	-322,000,000	1,190,000,000	3,162,000,000	2,217,000,000	3,606,000,000	2,089,000,000	518,000,000	1,464,000,000	360,000,000	-534,000,000	433,000,000	159,000,000	676,000,000	-589,000,000	-319,000,000	-1,016,000,000	119,000,000	-516,000,000	-905,000,000	-521,000,000	-99,000,000
effect of exchange rate changes on cash	25,000,000	13,000,000	26,000,000	1,000,000	-5,000,000	25,000,000	-22,000,000	17,000,000	11,000,000	48,000,000	-96,000,000	0	-20,000,000	7,000,000	-18,000,000	0	9,000,000	14,000,000	13,000,000	-26,000,000	-12,000,000	-9,000,000	-15,000,000	22,000,000	-19,000,000	3,000,000	7,000,000				7,000,000	-5,000,000	7,000,000
net increase in cash and cash equivalents, including amounts restricted	651,000,000	-530,000,000	2,536,000,000	784,000,000	-561,000,000	629,000,000	-741,000,000	-1,106,000,000	1,083,000,000	-860,000,000	233,000,000	571,000,000	-758,000,000	15,000,000	721,000,000	1,297,000,000	-1,367,000,000	-1,316,000,000	100,000,000
cash and cash equivalents, including amounts restricted at beginning of period	0	9,489,000,000
cash and cash equivalents, including amounts restricted at end of period	651,000,000	8,959,000,000
supplemental disclosures:
interest paid excluding consolidated investment entities	175,000,000	131,000,000	175,000,000	244,000,000	195,000,000	244,000,000	157,000,000	169,000,000	112,000,000	63,000,000	35,000,000	27,000,000	27,000,000	28,000,000	27,000,000	28,000,000	30,000,000	32,000,000	36,000,000	52,000,000	28,000,000	64,000,000	27,000,000	67,000,000	28,000,000	32,000,000
interest paid by consolidated investment entities	35,000,000	39,000,000	40,000,000	42,000,000	44,000,000	45,000,000	45,000,000	43,000,000	44,000,000	26,000,000	19,000,000	17,000,000	13,000,000	17,000,000	43,000,000	19,000,000	11,000,000	10,000,000	12,000,000	25,000,000	25,000,000	82,000,000	61,000,000	60,000,000	54,000,000
income taxes paid	672,000,000	28,000,000	108,000,000	82,000,000	25,000,000	240,000,000	112,000,000	651,000,000	33,000,000	133,000,000	201,000,000	132,000,000	34,000,000	119,000,000	229,000,000	602,000,000	36,000,000	120,000,000	65,000,000	152,000,000	23,000,000	194,000,000	165,000,000	59,000,000	21,000,000	50,000,000	209,000,000	89,000,000			43,000,000
leased assets obtained in exchange for operating lease liabilities	12,000,000	22,000,000	8,000,000	4,000,000	11,000,000	9,000,000	48,000,000	3,000,000	7,000,000	5,000,000	15,000,000	14,000,000	13,000,000	46,000,000	11,000,000	8,000,000	44,000,000	8,000,000	17,000,000
reconciliation of cash and cash equivalents, including amounts restricted:
cash and cash equivalents	156,000,000	7,806,000,000	3,058,000,000	446,000,000	7,071,000,000		-333,000,000	-1,043,000,000	8,386,000,000		330,000,000	866,000,000	6,623,000,000		615,000,000	1,659,000,000	5,462,000,000		-213,000,000
cash of consolidated investment entities	251,000,000	168,000,000	-227,000,000	216,000,000	135,000,000		-44,000,000	-27,000,000	162,000,000		102,000,000	-47,000,000	119,000,000		-27,000,000	-230,000,000	325,000,000		178,000,000
restricted and segregated cash, cash equivalents and investments	-75,000,000	1,304,000,000	-112,000,000	-218,000,000	1,591,000,000		-43,000,000	-372,000,000	1,984,000,000		-151,000,000	-174,000,000	2,668,000,000		-31,000,000	-182,000,000	2,564,000,000		135,000,000
less: restricted and segregated investments		-319,000,000	-183,000,000	340,000,000	-738,000,000		-321,000,000	336,000,000	-694,000,000		-48,000,000	-74,000,000	-599,000,000		164,000,000	50,000,000	-815,000,000
total cash and cash equivalents, including amounts restricted per consolidated statements of cash flows	651,000,000	8,959,000,000
cash and cash equivalents, including amounts restricted, at beginning of period			0	0	8,620,000,000		0	0	8,755,000,000		0	0	9,569,000,000		0	0	8,903,000,000		0
cash and cash equivalents, including amounts restricted, at end of period			2,536,000,000	784,000,000	8,059,000,000		-741,000,000	-1,106,000,000	9,838,000,000		233,000,000	571,000,000	8,811,000,000		721,000,000	1,297,000,000	7,536,000,000		100,000,000
total cash and cash equivalents including amounts restricted per consolidated statements of cash flows			2,536,000,000	784,000,000	8,059,000,000		-741,000,000	-1,106,000,000	9,838,000,000		233,000,000	571,000,000	8,811,000,000		721,000,000	1,297,000,000	7,536,000,000		100,000,000
cash received from purchased options with deferred premiums					26,000,000	0	101,000,000	142,000,000	8,000,000	148,000,000	62,000,000	0	168,000,000	770,000,000	238,000,000	36,000,000	306,000,000	0	1,000,000	0	33,000,000	8,000,000	0			47,000,000
changes in operating assets and liabilities
cash returned (paid) for acquisition of business, net of cash acquired										0	0
exercise of stock options																		1,000,000	0	2,000,000	2,000,000	2,000,000	3,000,000	5,000,000	6,000,000	11,000,000	18,000,000	26,000,000	26,000,000	48,000,000	32,000,000	5,000,000	40,000,000
leased assets obtained in exchange for finance lease liabilities
non-cash investing activities:
investments transferred in connection with fixed annuity reinsurance transaction
exchange of an investment that resulted in a realized gain and an increase to amortized cost														0	0	0	17,000,000
deferred taxes							-1,000,000	-5,000,000	7,000,000	-6,000,000	4,000,000	4,000,000	2,000,000	116,000,000	200,000,000	-197,000,000	-115,000,000
net realized investment gains								9,000,000	-7,000,000			9,000,000	-18,000,000									0	3,000,000	-5,000,000	-12,000,000	-6,000,000
policyholder account balances, future policy benefits and claims										679,000,000	601,000,000	321,000,000	-168,000,000	912,000,000	797,000,000	1,427,000,000	-1,050,000,000	-198,000,000	531,000,000	492,000,000	669,000,000	-187,000,000	864,000,000	-602,000,000	419,000,000	121,000,000	-294,000,000
funding and purchases of mortgage loans
issuance of long-term debt											0				0	0	4,000,000		-2,000,000
non-cash investing activity:
investments transferred in connection with reinsurance transaction
gain on disposal of business before affinity partner payment
changes in operating assets and liabilities, net of effects from acquisitions:
proceeds from disposal of business, net of cash and cash equivalents sold
cash paid for acquisition of business, net of cash acquired
partnership commitments not yet remitted																			2,000,000
impairments and benefit from loan losses															-5,000,000				-1,000,000
current income tax expense															-107,000,000	-376,000,000	90,000,000	125,000,000	282,000,000
cash paid for deposit receivable															-212,000,000	-2,000,000	-2,000,000	-1,000,000	-2,000,000
cash received for deposit receivable															88,000,000	23,000,000	21,000,000	19,000,000	21,000,000
borrowings by consolidated investment entities															0	578,000,000	797,000,000					67,000,000	815,000,000	569,000,000	199,000,000	478,000,000	538,000,000	133,000,000	587,000,000	467,000,000	92,000,000	79,000,000	4,000,000
net increase in cash and cash equivalents, including amounts restricted and cash balances classified as assets held-for-sale																			100,000,000
less: net change in cash balances classified as assets held for sale
net realized investment losses																				-6,000,000	12,000,000
net trading gains																				-2,000,000	-2,000,000	-2,000,000	-1,000,000	-1,000,000	-3,000,000	-2,000,000
other-than-temporary impairments and benefit from loan losses																						0	7,000,000	0	2,000,000	1,000,000	1,000,000	2,000,000	2,000,000	3,000,000	16,000,000	10,000,000	7,000,000
net incomees of consolidated investment entities
other investments																				-8,000,000	-4,000,000	20,000,000	8,000,000	108,000,000	-55,000,000		-4,000,000	-3,000,000			4,000,000
proceeds from sales and collections of other investments																				53,000,000	32,000,000	38,000,000	87,000,000	70,000,000	41,000,000	57,000,000
net increase in cash, cash equivalents and restricted cash
cash, cash equivalents and restricted cash at beginning of period
net cash outflows upon the deconsolidation of vies
cash, cash equivalents and restricted cash at end of period
reconciliation of cash, cash equivalents and restricted cash:
restricted and segregated cash and investments																				34,000,000	49,000,000	-247,000,000	-211,000,000	222,000,000	-99,000,000	-31,000,000	-100,000,000	-22,000,000	-49,000,000	264,000,000
total cash, cash equivalents and restricted cash per consolidated statements of cash flows
net incomees (gains) of consolidated investment entities																				1,000,000	4,000,000						-73,000,000
cash held by consolidated investment entities																				-85,000,000	9,000,000	287,000,000	-315,000,000	-131,000,000	52,000,000	-72,000,000	-75,000,000
investment properties of consolidated investment entities																						12,000,000	-187,000,000	94,000,000	-33,000,000	49,000,000	-246,000,000
excess tax benefits from share-based compensation																				2,000,000	3,000,000	11,000,000	16,000,000	9,000,000	45,000,000	92,000,000	19,000,000	24,000,000	26,000,000	51,000,000	13,000,000	13,000,000	15,000,000
noncontrolling interests investments in subsidiaries																						30,000,000	90,000,000	18,000,000	117,000,000		102,000,000	209,000,000	5,000,000	76,000,000	61,000,000	58,000,000	4,000,000
distributions to noncontrolling interests																						-73,000,000	-13,000,000	-110,000,000	-219,000,000	-49,000,000	-19,000,000
net increase in cash and cash equivalents																				170,000,000	292,000,000	-423,000,000			171,000,000		-493,000,000
cash and cash equivalents at beginning of period																				0	2,357,000,000	0	0	0	2,638,000,000	2,632,000,000	0	0	0	2,371,000,000	0	0	2,781,000,000
cash and cash equivalents at end of period																				170,000,000	2,649,000,000	-423,000,000	210,000,000	-239,000,000	2,809,000,000	2,403,000,000	-493,000,000	794,000,000	171,000,000	2,160,000,000	604,000,000	409,000,000	2,312,000,000
affordable housing partnership commitments not yet remitted																				9,000,000	10,000,000	36,000,000	0	-1,000,000	10,000,000		70,000,000	-2,000,000	18,000,000	10,000,000	-6,000,000
loss (income) from equity method investments																										3,000,000
net gains of consolidated investment entities																						-47,000,000			-9,000,000	-101,000,000
net transfers to separate accounts																						-30,000,000	-39,000,000	-46,000,000	-56,000,000	-56,000,000
change in short-term borrowings																										-200,000,000	0
deferred income tax benefit
proceeds from maturities and repayments of mortgage loans																							162,000,000	156,000,000	163,000,000	140,000,000
issuance of debt, net of issuance costs																											151,000,000
repayments of debt
net decrease in cash and cash equivalents																										-229,000,000
net trading losses
loss (income) and (gain) from sale of equity method investments
funding and purchase of mortgage loans
proceeds from sale of business
change in credit card receivables
consolidated statements of cash flows (continued) ameriprise financial, inc.
investment certificates and banking time deposits:
change in other banking deposits																																200,000,000	149,000,000
interest paid before consolidated investment entities																											46,000,000	34,000,000	55,000,000	35,000,000	38,000,000	58,000,000	37,000,000
non-cash financing activity:
dividends declared but not paid
net unrealized trading losses																															1,000,000
loss (income) and gain from sale of equity method investments
proceeds from sales, maturities and repayments of commercial mortgage loans																												78,000,000	72,000,000	79,000,000	62,000,000	89,000,000	46,000,000
funding of commercial mortgage loans
proceeds from sales of other investments																												48,000,000	133,000,000	67,000,000	38,000,000	45,000,000	53,000,000
change in consumer loans																												52,000,000	41,000,000	50,000,000
ameriprise financial, inc. consolidated statements of cash flows
consideration received																												371,000,000	346,000,000	303,000,000	334,000,000	356,000,000	392,000,000
future policy benefits and claims																															235,000,000	-225,000,000	294,000,000
policyholder and contractholder account values:
derivatives collateral
deferred premium options
income taxes paid (received)																														10,000,000
net income of consolidated investment entities																															34,000,000
change in consumer banking loans and credit card receivables
net income (income) attributable to noncontrolling interests
changes in operating assets and liabilities before consolidated investment entities:
changes in operating assets and liabilities of consolidated investment entities																																	14,000,000
restricted and segregated cash
change in deferred acquisition costs
trading securities and equity method investments
acquisitions

We provide you with 20 years of cash flow statements for Ameriprise Financial stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Ameriprise Financial stock. Explore the full financial landscape of Ameriprise Financial stock with our expertly curated income statements.

The information provided in this report about Ameriprise Financial stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.